Home » Trials » SLCTR/2013/025


An intervention to improve mental health care for conflict-affected forced migrants in low-resource settings: A WHO MhGAP based pilot study in primary care setting in Sri Lanka

-

SLCTR Registration Number

SLCTR/2013/025


Date of Registration

13 Aug 2013

The date of last modification

Mar 03, 2019


Trial Status



Application Summary


Scientific Title of Trial

An intervention to improve mental health care for conflict-affected forced migrants in low-resource settings: A WHO MhGAP based pilot study in primary care setting in Sri Lanka


Public Title of Trial

Improving primary mental health care for forced migrants through training primary care practitioners in Sri Lanka: a feasibility pilot study


Disease or Health Condition(s) Studied

Depression, Medically unexplained symptoms, Alcohol use disorders, Suicidal ideations


Scientific Acronym

COM-GAP


Public Acronym

None


Brief title

None


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

730/13 (Ethics review committee of Faculty of Medical Sciences, University of Sri Jayawardenepura)


Trial Details


What is the research question being addressed?

Will WHO mhGAP IG (mental health Gap Action Programme - Intervention Guide) based training for primary care practitioners (PCP) increase rates of correct identification, treatment and specialist referral of patients with common mental disorders (CMD) among conflict-affected forced migrants in low-resource settings?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Single blinded


Control

Standard therapy/practice


Assignment

Parallel


Purpose

Health services research


Study Phase

Not Available


Intervention(s) planned

The study will be carried out in primary care settings in Puttalam and Mannar districts of Sri Lanka, All PCPs recruited to the study will be randomized to intervention and control arms. All will be provided an initial training on ethics and informed consent process.

Both arms will be monitored for 90 days. During this period, all PCPs will be required to immediately inform the study coordinator upon diagnosing a primary care patient with CMD.

Training based on WHO mhGAP IG will then be provided to the intervention arm. Only relevant modules (depression, medically unexplained symptoms, alcohol abuse and suicide) will be used. Training will take place on a full day basis for five days.

Both arms will then be monitored for another 90 days. All PCPs will be required to immediately inform the study coordinator upon diagnosing a primary care patient with CMD. There will be no randomization of patients into the two arms of the study.

Patients will be approached individually and consenting patients will be directed to the study psychiatrist, who will re-assess them based on mhGAP-based criteria for concurrence with the initial PCP diagnosis.

For those patients categorised as referrals to specialist care, treatment and management will be provided by the study psychiatrist unless preferred otherwise by the patients.

The study psychiatrist will be blind/masked to the randomization status of PCP. In addition, patients will also be blind to the PCP randomization status.

At the end of the study, the training intervention will be provided to PCPs in the control arm.


Inclusion criteria

For PCPs. 1. At least 5 years’ service 2. Full registration with the Sri Lanka Medical Council 3. Provision of primary care to IDP populations at least four hours a day.

For the patients 1. Meet the definition of an IDP (specifically, Northern Muslims) 2. 18 years or older


Exclusion criteria

For PCPs 1. Psychiatrists, 2. Having secondary mental health training

For patients 1. Existing diagnosis of a serious mental disorders



Primary outcome(s)

1.

Referral rates

[

Continuously until the end of the second 90 day observation period

]
2.

Rates of study psychiatrist verified diagnosis

[

At the time of each patient recruitment

]
3.

Quality of adherence to mhGAP guidelines

[

At the end of the first and second 90 day observation period

]
4.

Change in knowledge levels (using mhGAP IG pre/post training tests)

[

At PCP recruitment to study, at first day of training, at last day of training and at end of study.

]

Secondary outcome(s)

1.

Attitudes, views and perceptions of PCP on integrating mental health in to primary health care (using qualitative methods)

[

At the time of recruitment of PCPs

]
2.

Economic evaluation (using Client Receipt Service Inventory)

[

At recruitment and at the end of the second 90 day follow up period

]
3.

Total cost of training PCP and service provision costs

[

At the end of the second 90 day follow up period

]
4.

CMD outcomes of patients

[

At the end of the second 90 day follow up period

]

Target number/sample size

43 PCP for each arm (total of 86) [feasibility study]


Countries of recruitment

Sri Lanka


Anticipated start date

2013-09-01


Anticipated end date

2014-08-01


Date of first enrollment


Date of study completion


Recruitment status

Pending


Funding source

SHARE consortium, supported by the NIMH grant number 1U19MH095687-01


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2013-05-27


Approval number

730/13


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura
Institutional Address:Gangodawila, Nugegoda Sri Lanka
Telephone:+94-112758000 (Extension: 4075)
Email: erc.fms.usjp@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr. Chesmal Siriwardhana
Research Fellow
Institute for Research & Development, 393/3, Lily Avenue, Off Robert Gunawardene Mw, Battaramulla, Sri Lanka
+94 112 863084

+94 112 863084
chesmal@gmail.com

Contact Person for Public Queries

Dr Athula Sumathipala
Senior Lecturer, Department of Health Service and Population Research, Kings College London and Director Institute for Research and Development, Sri Lanka
Institute for Research & Development, 393/3, Lily Avenue, Off Robert Gunawardene Mw, Battaramulla, Sri Lanka
+94 112 863084

+94 112 863084
athula.sumathipala.kcl.ac.uk


Primary study sponsor/organization

Institute for Research & Development

393/3, Lily Avenue, Off Robert Gunawardene Mw, Battaramulla, Sri Lanka
+94 112 863084
+94 112 863084
forum4research@gmail.com
www.ird.lk

Secondary study sponsor (If any)

South Asia Hub for Advocacy, Research and Education in Mental Health (SHARE) Consortium.





http://www.centreforglobalmentalhealth.org

Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results